The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early assessment of PSA response in CRPC patients treated with enzalutamide (Enza) or abiraterone (Abi).
 
Jeffrey R. Guccione
No Relationships to Disclose
 
Elisa M. Ledet
No Relationships to Disclose
 
Michael D. Stolten
No Relationships to Disclose
 
Allie E. Steinberger
No Relationships to Disclose
 
Lydia D. Chow
No Relationships to Disclose
 
Patrick Cotogno
Research Funding - Bayer (Inst); Dendreon (Inst); Exelixis (Inst); Janssen (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst); Tokai Pharmaceuticals (Inst)
 
Brian E. Lewis
No Relationships to Disclose
 
A. Oliver Sartor
Consulting or Advisory Role - Algeta ASA; Aragon Pharmaceuticals; Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Biscayne Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Pfizer; Sanofi
Research Funding - Algeta ASA (Inst); Bayer (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst)